André Bortolini Silveira

André Bortolini Silveira

Auto-generated profile, based on publicly available information

André Bortolini Silveira

Inserm U830, DNA Repair and Uveal Melanoma (D.R.U.M.), Institut Curie, PSL Research University, Paris, France

Research Focus & Metrics

Academic Career Length

18Years (2009-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
4 September 2011 in Nature Genetics
Verified
Journal Article
Closed access
PDF file
PZPriscila P Zenatti
Priscila P Zenatti
DRDaniel Ribeiro
Daniel Ribeiro
WLWenqing Li
Wenqing Li
LZLinda Zuurbier
Linda Zuurbier
MSMilene Costa da Silva
Milene Costa da Silva
João T BarataJoão T Barata
João T Barata

1 January 2019 in Cancer Cell
Verified
Journal Article
Closed access
JLJon D. Larson
Jon D. Larson
LKLawryn H. Kasper
Lawryn H. Kasper
BPBarbara S. Paugh
Barbara S. Paugh
HJHongjian Jin
Hongjian Jin
GWGang Wu
Gang Wu
SBSuzanne Baker
Suzanne Baker

15 February 2019 in Acta Neuropathologica
Verified
Journal Article
Closed access
PDF file
ASAndré B. Silveira
André B. Silveira
LKLawryn H. Kasper
Lawryn H. Kasper
YFYiping Fan
Yiping Fan
HJHongjian Jin
Hongjian Jin
GWGang Wu
Gang Wu
SBSuzanne Baker
Suzanne Baker

16 December 2009 in Haematologica
Verified
Journal Article
Closed access
ASA. Silva
A. Silva
PJP. Y. Jotta
P. Y. Jotta
ASA. B. Silveira
A. B. Silveira
DRDaniel Ribeiro
Daniel Ribeiro
SBS. R. Brandalise
S. R. Brandalise
João T BarataJoão T Barata
João T Barata
T-cell acute lymphoblastic leukemia (T-ALL) patients frequently display NOTCH1 activating mutations and Notch can transcriptionally down-regulate the tumor suppressor PTEN. However, it is not clear whether NOTCH1 mutations associate with decreased PTEN expression in primary T-ALL. Here, we compared patients with or without NOTCH1 mutations and report that the former presented higher MYC transcript levels and decreased PTEN mRNA expression. We recently showed that T-ALL cells frequently display CK2-mediated PTEN phosphorylation, resulting in PTEN protein stabilization and concomitant functional inactivation. Accordingly, the T-ALL samples analyzed, irrespectively of their NOTCH1 mutational status, expressed significantly higher PTEN protein levels than normal controls. To evaluate the integrated functional impact of Notch transcriptional and CK2 post-translational inactivation of PTEN, we treated T-ALL cells with both the gamma-secretase inhibitor DAPT and the CK2 inhibitors DRB/TBB. Our data suggest that combined use of gamma-secretase and CK2 inhibitors may have therapeutic potential in T-ALL.

1 May 2015 in European Journal of Medicinal Chemistry
Verified
Journal Article
Closed access
LSLívia B. Salum
Lívia B. Salum
AMAlessandra Mascarello
Alessandra Mascarello
RCRafael R. Canevarolo
Rafael R. Canevarolo
WAWanessa Fernanda Altei
Wanessa Fernanda Altei
ALAngelo B.A. Laranjeira
Angelo B.A. Laranjeira
RNRicardo J. Nunes
Ricardo J. Nunes

1 April 2015 in Oncotarget
Verified
Journal Article
Open access
PDF file
ASAndré Bortolini Silveira
André Bortolini Silveira
ALAngelo Brunelli Albertoni Laranjeira
Angelo Brunelli Albertoni Laranjeira
GRGisele Olinto Libanio Rodrigues
Gisele Olinto Libanio Rodrigues
PLPaulo César Leal
Paulo César Leal
BCBruno António Cardoso
Bruno António Cardoso
JYJosé Andrés Yunes
José Andrés Yunes
PI3K inhibition synergizes with glucocorticoids but antagonizes with methotrexate in T-cell acute lymphoblastic leukemia PI3K inhibition synergizes with glucocorticoids but antagonizes with methotrexate in T-cell acute lymphoblastic leukemia